All Stories

  1. Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway

    Article • British Journal of Pharmacology, May 2016, Wiley

    Melissa García Caballero